ISCD Learning
Catalog Advanced Search
-
Both ACCME and ASRT Credits
Expires 7/14/2027: This talk will examine the role of DXA in diagnosing sarcopenia, highlighting its accessibility and value for estimating lean mass in clinical and research settings. It will critically discuss key limitations, including variability across devices, cut-off definitions, and the inability of DXA to capture muscle mass, quality and function. Practical implications for clinicians will be addressed, with guidance on how to interpret DXA findings within a comprehensive sarcopenia assessment. The second talk reviews the clinical application of bone turnover markers in osteoporosis management, with emphasis on monitoring response to oral bisphosphonate therapy. The lecture explains practical approaches for interpreting CTX, P1NP, and other markers to assess adherence, identify responders, and guide treatment decisions during and after therapy.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires July 14, 2027Activity Description
This talk will examine the role of DXA in diagnosing sarcopenia, highlighting its accessibility and value for estimating lean mass in clinical and research settings. It will critically discuss key limitations, including variability across devices, cut-off definitions, and the inability of DXA to capture muscle mass, quality and function. Practical implications for clinicians will be addressed, with guidance on how to interpret DXA findings within a comprehensive sarcopenia assessment. The second talk reviews the clinical application of bone turnover markers in osteoporosis management, with emphasis on monitoring response to oral bisphosphonate therapy. The lecture explains practical approaches for interpreting CTX, P1NP, and other markers to assess adherence, identify responders, and guide treatment decisions during and after therapy.
Learning Objectives:
- Differentiate sarcopenia as a disease from normal age-related changes in lean mass.
- Evaluate the clinical usefulness and limitations of DXA for assessing lean mass in suspected sarcopenia and osteosarcopenia.
- Describe emerging approaches and consensus efforts for defining and diagnosing sarcopenia, including the role of muscle mass, strength, and outcomes.
- Identify key sources of variability in bone turnover marker testing, including circadian rhythm, food intake, age, sex, and recent fracture.
- Apply least significant change and reference targets to determine whether a patient is responding to osteoporosis therapy.
- Use bone turnover markers to monitor adherence, treatment response, and offset of effect after oral bisphosphonate therapy.
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on July 15th, 2026.
Gustavo Duque, MD, PhD, FRACP, FGSA
Professor of Medicine and Director of the Division of Geriatric Medicine
McGill University
Dr. Gustavo Duque, MD, PhD, FRACP, is a geriatrician and biomedical scientist with a research interest in the mechanisms, potential therapies, and biomarkers for age-related bone loss, osteoporosis, sarcopenia, osteosarcopenia, and frailty in older persons. He also studies the effects of vitamin D, exercise, and protein intake on bone and muscle mass.
His initial training included Internal Medicine at Javeriana University (Colombia) and Geriatric Medicine, which he completed at McGill University in Montreal (Canada). He obtained his PhD at McGill University in 2003 with a thesis entitled “Molecular Changes of the Aging Osteoblast” under the supervision of Dr. Richard Kremer. Between 2003 and November 2007, he joined the McGill University Medical School faculty as a member of the Division of Geriatric Medicine and as a Researcher at the Lady Davis Institute for Medical Research.
In November 2007, he moved to Australia to join the faculty as Associate Professor and Head of the Division of Geriatric Medicine and Director of the Musculoskeletal Ageing Research Program at Sydney Medical School Nepean, University of Sydney. In 2012, he was promoted to Professor of Medicine at the University of Sydney. Between 2015 and 2022, Dr. Duque held the positions of Chair of Medicine and Director of the Australian Institute for Musculoskeletal Science at the University of Melbourne.
In 2022, Dr. Duque assumed the roles of Full Professor, Dr. Joseph Kaufmann Chair in Geriatric Medicine, Director of the RUISSS McGill Centre of Excellence for Sustainable Health of Seniors/Simone & Edouard Shouela (CEDurable), and Principal Investigator in the Bone, Muscle & Geroscience Group at the Research Institute of the McGill University Health Centre (MUHC). He is also the Editor-in-Chief of the Journal of Gerontology: Biological Sciences, one of the official journals of the Gerontological Society of America. In 2025, he became Director of the McGill Division of Geriatric Medicine.
As a geriatrician and clinician-investigator, Dr. Duque has implemented several Falls and Fractures clinics—including the most recent at the McGill University Health Centre and the Jewish General Hospital in Montreal—where patients are comprehensively assessed for fall and fracture risk. His clinical trials unit conducts multiple studies evaluating pharmacological and non-pharmacological therapies for age-related musculoskeletal diseases. He is the author of more than 360 peer-reviewed articles and multiple book chapters and has edited five books in the aging and musculoskeletal fields, including two on osteosarcopenia.
Richard Eastell, MD
Professor and Head of the Academic Unit of Bone Metabolism
University of Sheffield
Dr. Richard Eastell is a Professor and Head of the Academic Unit of Bone Metabolism at the University of Sheffield–Sheffield Teaching Hospitals NHS Trust and Director of the Mellanby Centre for Bone Research in Sheffield, UK. He is an internationally recognized expert in osteoporosis, bone metabolism, and bone turnover markers.
Professor Eastell holds several prestigious positions including National Institute for Health Research Senior Investigator Emeritus status and serves on the International Osteoporosis Foundation Committee of Scientific Advisors. He has held leadership roles with the European Calcified Tissue Society (Program Co-Chair), serves as Treasurer for IBMS, and sits on editorial boards for Endocrine Reviews and Lancet Diabetes and Endocrinology. He also serves as Senior Editor for the journal Bone.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 8/1/2027: This session will provide DXA technologists with an overview of less commonly used DXA features and companion technologies that extend the clinical utility of standard bone density testing. Participants will review specialized DXA features including vertebral fracture assessment (VFA), full femur imaging (FFI), lateral distal femur (LDF) imaging, and orthopedic applications, with emphasis on utility, indications, acquisition techniques and analysis. The program will also address performance of additional DXA-derived analyses such as FRAX and hip geometry, highlighting technologist responsibilities in data accuracy and workflow integration. In addition, participants will explore the role of DXA companion software—including trabecular bone score (TBS) and 3D Shaper to better understand their technical requirements, outputs, and clinical relevance in comprehensive skeletal assessment.
Activity approved for 2.00 ASRT Category A Credits
Activity Expires August 1, 2027Activity Description
This session will provide DXA technologists with an overview of less commonly used DXA features and companion technologies that extend the clinical utility of standard bone density testing. Participants will review specialized DXA features including vertebral fracture assessment (VFA), full femur imaging (FFI), lateral distal femur (LDF) imaging, and orthopedic applications, with emphasis on utility, indications, acquisition techniques and analysis. The program will also address performance of additional DXA-derived analyses such as FRAX and hip geometry, highlighting technologist responsibilities in data accuracy and workflow integration. In addition, participants will explore the role of DXA companion software—including trabecular bone score (TBS) and 3D Shaper to better understand their technical requirements, outputs, and clinical relevance in comprehensive skeletal assessment.
Learning Objectives
- Describe enhanced DXA features, including vertebral fracture assessment (VFA), full femur imaging (FFI), lateral distal femur (LDF), and orthopedic hip protocols.
- Perform additional analyses derived from DXA scans, including FRAX and hip geometry.
- Discuss the utility of DXA companion software, including trabecular bone score (TBS) and 3D Shaper.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 2.00 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on July 15th, 2026.
Diane Krueger, BS, CCRC, CBDT
Researcher
Osteoporosis Clinical Research Program - University of Wisconsin, Madison
Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993 and researcher since 2021. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 100 manuscripts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Committee in addition to the Annual Meeting Committee. In her leadership capacity, she has served as Education Council chair, Executive Committee and Board. Additionally, she held several officer positions including Secretary and four Presidential seats.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 7/14/2027: In this session, I will be examining differences in bone mineral density (BMD) and fracture risks in different racial and ethnic populations. BMD is determined by a complex interplay of genetic factors, lifestyle, hormonal levels, and physical characteristics, with approximately 60% to 80% of peak bone mass variance attributed to genetics. Race and ethnicity are significant independent determinants of BMD, influencing peak bone mass, rate of bone loss, and overall fracture risk. I will also be discussing how this information can be used to translate to better patient care.
Activity approved for 0.50 AMA PRA Category 1 Credits™
Activity approved for 0.75 ASRT Category A Credits
Activity Expires July 14, 2027Activity Description
In this session, I will be examining differences in bone mineral density (BMD) and fracture risks in different racial and ethnic populations. BMD is determined by a complex interplay of genetic factors, lifestyle, hormonal levels, and physical characteristics, with approximately 60% to 80% of peak bone mass variance attributed to genetics. Race and ethnicity are significant independent determinants of BMD, influencing peak bone mass, rate of bone loss, and overall fracture risk. I will also be discussing how this information can be used to translate to better patient care.
Learning Objectives
- Understand that race and ethnicity are significant determinants of BMD and fracture risks
- Explain why these differences may create myths and affect care
- Individualize osteoporosis treatments based on race and ethnicity
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 0.75 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on July 15th, 2026.
Angela M. Cheung, MD, PhD, FRCPC
Professor of Medicine
University of Toronto, Canada
Dr. Angela M. Cheung is Professor of Medicine, KY and Betty Ho Chair of Integrative Medicine at University of Toronto (UT) and Senior Physician Scientist at University Health Network (UHN). She is the Founding Director of University Health Network Osteoporosis Program and the Founding Director of University of Toronto Centre of Excellence in Skeletal Health Assessment (CESHA). She currently holds a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. She has won other awards over the years, including the ASBMR Gideon Rodan Mentorship award, ECTS research excellence award, Canadian Institutes of Health Research (CIHR) Senior Investigator award, and the Canadian Society of Internal Medicine (CSIM) David Sackett Senior Investigator award. She is President of the International Society of Clinical Densitometry, member of International Osteoporosis Foundation Council of Scientific Advisors, and past chair of Osteoporosis Canada Scientific Advisory Council. She obtained her M.D. from Johns Hopkins University School of Medicine in 1988, and her PhD from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for >35 years.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 7/14/2027: AFFs are associated with some osteoporosis treatments and may occur without any treatment. The risk of AFF for most patients is very low and can be minimized with appropriate care. This presentation will address strategies for early recognition AFF, treatment of incomplete and complete AFF, and management of osteoporosis after AFF.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires July 14, 2027Activity Description
AFFs are associated with some osteoporosis treatments and may occur without any treatment. The risk of AFF for most patients is very low and can be minimized with appropriate care. This presentation will address strategies for early recognition AFF, treatment of incomplete and complete AFF, and management of osteoporosis after AFF.
Learning Objectives
- Identify standards for diagnosing atypical femur fractures (AFF)
- Describe risk factors for AFF
- Discuss strategies for prevention of AFF
- Review the risks, epidemiological patterns, and clinical features of atypical femoral fractures (AFFs).
- Discuss differential management of AFF linked to bisphosphonate or denosumab therapy, including areas of uncertainty.
- Evaluate the clinical implications of current AFF knowledge in the context of anti-osteoporosis pharmacotherapy.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on July 15th, 2026.
E. Michael Lewiecki, MD, FACP, FACE, CCD
Director
New Mexico Clinical Research & Osteoporosis Center, Inc.
E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.
WuQiang Fan, MD, PhD
Director of Fracture Liaison Service, Assistant Professor of Medicine
Massachusetts General Hospital, Harvard Medical School
Dr. WuQiang Fan (pronounced as “Wu-Chiang Fan”) earned his medical degree from Zhejiang University School of Medicine in China. He subsequently completed his PhD in molecular biology at Kyushu University in Japan, where he investigated steroid hormone receptor signaling and transcriptional regulation. He then pursued postdoctoral research on diabetes and insulin signaling at the University of California, San Diego School of Medicine, before undertaking internal medicine residency training at Drexel University College of Medicine. In 2016, he began his endocrinology fellowship at Massachusetts General Hospital (MGH), where he remained on faculty following graduation. His clinical interests focus on metabolic bone disease and diabetes. He currently serves as Director of the MGH Fracture Liaison Service and Fracture Secondary Prevention Program, and as one of the Associate Program Directors of the MGH Endocrinology Fellowship Training Program. He is an Assistant Professor of Medicine at Harvard Medical School.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 6/14/2027: This session will prepare DXA technologists to effectively support patient education and engagement within their professional scope of practice. Participants will explore strategies for appropriate technologist–patient communication related to fracture prevention, bone health, nutrition, supplementation, and lifestyle modification, with emphasis on the use of motivational interviewing techniques to encourage positive health behaviors. The program will also guide technologists in identifying reliable patient education materials suitable for distribution in the DXA setting. In addition, participants will review the role of physical activity and weight-bearing exercise in maintaining bone and muscle health, enabling technologists to reinforce consistent, evidence-based messaging while supporting referring provider recommendations.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires June 14, 2027Activity Description
This session will prepare DXA technologists to effectively support patient education and engagement within their professional scope of practice. Participants will explore strategies for appropriate technologist–patient communication related to fracture prevention, bone health, nutrition, supplementation, and lifestyle modification, with emphasis on the use of motivational interviewing techniques to encourage positive health behaviors. The program will also guide technologists in identifying reliable patient education materials suitable for distribution in the DXA setting. In addition, participants will review the role of physical activity and weight-bearing exercise in maintaining bone and muscle health, enabling technologists to reinforce consistent, evidence-based messaging while supporting referring provider recommendations.
Learning Objectives
- Discuss appropriate technologist–patient communication regarding fracture prevention, bone health, nutrition, supplementation, and lifestyle modification using motivational interviewing techniques.
- Locate examples of patient educational materials suitable for technologist distribution.
- Explain the importance of physical activity and weight-bearing exercise in maintaining bone and muscle health.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on June 15th, 2026.
Leah Prestbo, MD, CCD
Medical Director
Avera Bone Health Program, Sioux Falls, SD
Dr. Leah Prestbo, MD, CCD is a Family Medicine Physician with a passion for Bone Health and Osteoporosis care and education. She spends her time seeing patients in Bone Health Clinic, reading DXA scans, and supporting Bone Health services, clinicians, clinics, and education as Medical Director of Bone Health for Avera Health.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 6/14/2027: This session will provide DXA technologists with a focused, practical framework for acquiring, analyzing, and reporting body composition data tailored to the needs of diverse clinical specialties. Participants will review primary DXA-derived body composition metrics—including appendicular lean mass (ALM), visceral adipose tissue (VAT), and fat mass index (FMI)—and learn how their clinical relevance differs across geriatrics, bariatrics, and sports medicine. The program will emphasize identification of the most appropriate body composition outputs for monitoring patient progress in metabolic risk assessment, eating disorder recovery, and athletic performance. In addition, the session will explore the clinical significance of regional versus total body composition measurements, enabling technologists to better support referring providers through accurate data acquisition, interpretation, and communication.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires June 14, 2027Activity Description
This session will provide DXA technologists with a focused, practical framework for acquiring, analyzing, and reporting body composition data tailored to the needs of diverse clinical specialties. Participants will review primary DXA-derived body composition metrics—including appendicular lean mass (ALM), visceral adipose tissue (VAT), and fat mass index (FMI)—and learn how their clinical relevance differs across geriatrics, bariatrics, and sports medicine. The program will emphasize identification of the most appropriate body composition outputs for monitoring patient progress in metabolic risk assessment, eating disorder recovery, and athletic performance. In addition, the session will explore the clinical significance of regional versus total body composition measurements, enabling technologists to better support referring providers through accurate data acquisition, interpretation, and communication.
Learning Objectives
- Differentiate between the primary DXA metrics (such as ALM, VAT, and FMI) required by various specialties, including geriatrics, bariatrics, and sports medicine.
- Identify which body composition outputs are most relevant for tracking patient progress in metabolic risk assessment, eating disorder recovery, and athletic performance.
- Discuss the clinical significance of regional and total body composition data to better understand the diverse needs of referring providers.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on June 15th, 2026.
Jonathan Bennett, PhD
Epidemiology
University of Hawaiʻi Cancer Center
Dr. Jonathan Bennett's research focuses on the technical aspects of body composition assessment technologies and the relationships between body composition measures and disease risk. His PhD research identifies the qualities and capabilities of assessment technologies for the assessment of nutrition status. His current research identifies specific components of body composition and their role in disease prevention, risk, and/or progression. His studies range in populations from infants (0-5y) to older adults with functional decline, including specialized populations such as astronauts, athletes and patients with obesity or cancer. His current efforts focus on how targeting specific aspects of body composition can impact disease risk and treatment.
Dr. Bennett received his MSc in Kinesiology (California State University, Long Beach) and PhD in Nutrition (University of Hawai'i at Manoa) and is currently a fellow at the University of Hawai'i Cancer Center. His work has been recognized at national and international conferences and working groups; he also serves as a Body Composition expert for the International Atomic Energy Agency and is on the Scientific Advisory Board of the International Body Composition Symposium conference.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Not for Credit
This session will discuss the basics of positioning, technique, and analysis as well as examine decision making for advanced DXA analysis of GE-Lunar scans. This activity is NOT for credit.
Activity is NOT for credit
Activity Description
In the Basics of GE Lunar module, Anita Colquhoun, RTNM, MRT(N), CDT will discuss the basics of positioning, technique, and analysis.
In the Advanced GE Lunar module, Wendy Tolman-Andrews, BS, RT(BD), CBDT will examine decision making for advanced DXA analysis of GE-Lunar scans. She will demonstrate how bone mapping and soft tissue detection impact measurements. This module will identify challenges such as atypical anatomy and internal artifacts in the lumbar spine and femur.
Learning Objectives
- Demonstrate proper positioning.
- Use proper technique.
- Perform scan analysis
- Identify factors involved in accurate measurement of bone mineral density.
- Investigate decision making strategies for scan analysis using enCORE software.
- Explore challenges of proper assessment in the presence of anatomical variances.
Registration Fees
This activity is being offered at no cost for a limited time.
THIS ACTIVITY IS NOT FOR CREDIT.
Anita Colquhoun, RTNM, MRT(N), CDT
Charge Technologist
Women's College Hospital
Anita Colquhoun RTNM, MRT(N), CDT is the Charge Technologist in the Centre for Osteoporosis and Bone Health Women’s College Hospital, Toronto. She graduated as a Nuclear Medical Technologist with a specialty in Bone Mineral Density (BMD) and has been working in the field since the early 1990s. An active member of the ISCD Technologist Faculty since 2000 having served four terms on the Governing Board of the ISCD including serving as Secretary and Treasurer of the Board, and as chair of the ISCD Annual Meeting Committee from 2012 through to 2016. Anita was an Expert Panelist for the 2023 ISCD Position Development Conference, she is current Chair of the Quality Bone Densitometry Technologist Course Committee, faculty for the International BDC Technologist Course, and a member of the ISCD Education Council and Canadian Regional Panel. She has participated in a variety of research studies as well as co-authoring abstracts and papers, co-writer for the on-line beginner BMD course and developed a competency profile and best practise in BMD for the Ontario Association of Medical Radiation Sciences.
Wendy Tolman-Andrews, BS, RT(BD), CBDT
Radiologic Technologist
University of Connecticut - Farmington campus at UConn Health
Wendy Tolman-Andrews, BS, RT(BD), CBDT has been performing DXA bone densitometry since 1997. She’s a longtime active member of the ISCD on various committees and workgroups recently as part of “Ask an Expert”, Facility Accreditation, Patient Resources, and Strategic Planning. She is honored to have received the Sydney Bonnick Award, ISCD Technologist of the Year, and the Paul D. Miller Service Award. Wendy currently works at the University of Connecticut’s Farmington campus at UConn Health.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - Free!
- Full Member - Free!
- MOC Only - Free!
- Community Member - Free!
- Professional Member - Free!
- More Information
-
Not for Credit
This session will discuss the basics of positioning, technique, and analysis as well as identify challenges such as anomalies and artifacts of the spine, transitional vertebrae, and surgical hardware. This activity is NOT for credit.
Activity is NOT for credit
Activity Description
In the Basics of Hologic module, Lawrence Jankowski, CBDT and Kyla Kent, BA, CBDT will discuss the basics of positioning, technique, and analysis.
In the Advanced Hologic module, Lawrence Jankowski, CBDT and Kyla Kent, BA, CBDT will identify challenges such as anomalies and artifacts of the spine, transitional vertebrae, and surgical hardware.
Learning Objectives
- Demonstrate proper positioning.
- Use proper technique.
- Perform scan analysis
- Measure accurate bone mineral density.
- Calculate fracture risk assessment.
- Perform body composition analysis.
Registration Fees
This activity is being offered at no cost for a limited time.
THIS ACTIVITY IS NOT FOR CREDIT.
Lawrence Jankowski, CBDT
Chief DXA Technologist/Research Coordinator
Illinois Bone and Joint Institute, LLC
Lawrence Jankowski is the chief DXA technologist and a research coordinator for Illinois Bone and Joint Institute, a multi-disciplinary 100+ physician practice with over 20 locations within Chicago and surrounding suburbs, specializing in orthopedic and rheumatologic health and sports performance and fitness. He started clinical imaging as a nuclear medicine technologist in 1978, performing both single- and dual- photon absorptiometry in beginning in 1987, and switched to DXA in 1990. He is also registered in radiology (limited), and is certified by the International Society for Clinical Densitometry (ISCD) first as a CDT in 1996, and then CBDT in 2001.
In addition to his clinical and research duties, he is a technical instructor for the ISCD bone density courses, serves on the editorial board for the Journal of Clinical Densitometry, chairman of the Facility Accreditation Program, He has presented numerous posters on bone densitometry at scientific meetings, including the ASBMR, AAOS, NOF, as well as ISCD. Most recently, he served as task force chair for the 2019 Position Development Conference on cross-calibration and LSC determination in multiple scanner environments.Kyla Kent, BA, CBDT
Technical Director
SAMBA Lab, Stanford University School of Medicine
Kyla Kent, BA, CBDT has been with Stanford University School of Medicine since 1991 in Adult Endocrine, Stanford Prevention Research Center and lastly as Technical Director of the Stanford Assessments of Muscle and Bone across the ages (SAMBA) Lab under the department of Pediatrics. Responsibilities include clinical facility management, protocol development, supervision of clinical staff, performance of DXA, HRpQCT, Biodex, functional strength assessments and other measures related to research conducted in the areas of childhood and adolescent bone health, bone metabolism, structural assessment, body composition, exercise, sleep, sarcopenia and healthy aging. Ms. Kent is a consultant in study design and instructor in bone density related imaging modalities for both the Palo Alto VA Hospital and Stanford Hospital, Stanford Children’s Hospital and the Stanford School of Medicine and internationally for bone mass measurement technique and analysis in growing skeletons. Ms. Kent is an active member of the International Society for Clinical Densitometry (ISCD). She joined at its beginning, did take a short hiatus and rejoined when ISCD met in San Francisco to be on the test committee. She has served on many committees over the years and currently is chair of the 2026 Tech symposium, serves on the pediatric and body composition faculties and Ask an Expert. She has served on the Facility Accreditation committee since its inception in 2011. She has acted as the Director, clinical instructor and lecturer for one of the few California certified, Limited License x-ray permit in DXA training program in Oakland, CA.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - Free!
- Full Member - Free!
- MOC Only - Free!
- Community Member - Free!
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2026: Sarcopenia, the age-related loss of muscle mass and function, is often considered in the context of osteoporosis and fractures. Despite this, progress in clinical recognition and treatment of sarcopenia has been limited. Sarcopenia today seems comparable to osteoporosis prior to 1990; a disease without widespread clinical diagnosis for which no pharmacologic therapy exists. Moreover, the pathogenesis of sarcopenia and osteoporosis are strikingly similar. Nonetheless, consideration of sarcopenia by osteoporosis clinicians can be done today; reasonable current, and potential future, clinical approaches will be considered.
Activity approved for up to 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires October 14, 2026Activity Description
Sarcopenia, the age-related loss of muscle mass and function, is often considered in the context of osteoporosis and fractures. Despite this, progress in clinical recognition and treatment of sarcopenia has been limited. Sarcopenia today seems comparable to osteoporosis prior to 1990; a disease without widespread clinical diagnosis for which no pharmacologic therapy exists. Moreover, the pathogenesis of sarcopenia and osteoporosis are strikingly similar. Nonetheless, consideration of sarcopenia by osteoporosis clinicians can be done today; reasonable current, and potential future, clinical approaches will be considered.
Learning Objectives:
- Make use of a syndrome approach to reducing “osteoporosis-related” fractures.
- Appreciate challenges in operationalizing the diagnosis of sarcopenia.
- Summarize rational approaches to non-pharmacologic fracture risk reduction therapy including calcium, vitamin D, protein and exercise/falls risk reduction.
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15, 2025.
Neil Binkley MD, CCD
Professor of Medicine
University of Wisconsin Madison
Dr. Neil Binkley is a Professor in the Division of Geriatrics at the University of Wisconsin-Madison School of Medicine and Public Health. He is Director of the UW Osteoporosis Clinical Research Program, Associate Director of the UW Institute on Aging, past President of the International Society for Clinical Densitometry and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. He has published over 380 peer-reviewed manuscripts, virtually all of which are related to osteoporosis diagnosis/treatment, Orthopedic bone health management prior to elective surgery or following fracture and nutrition including vitamin D status/measurement.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $25
- Full Member - Free!
- MOC Only - Free!
- Community Member - $25
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2026: Osteoporosis is a very significant disease with increased fracture risk. This session will explore various ways to approach prevention in patients.
Activity approved for up to 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 14, 2026Activity Description
Osteoporosis is a very significant disease with increased fracture risk. This session will explore various ways to approach prevention in patients.
Learning Objectives:
- Understand the magnitude of changes in bone density and microarchitecture that occur during the menopause transition.
- Know how to identify women at high risk for developing osteoporosis.
- Appreciate a long-term strategy for preventing osteoporosis.
Instructions:
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15, 2025.
Michael R. McClung, MD, FACP, FASBMR
Oregon Osteoporosis Center
Portland, Oregon, USA.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $25
- Full Member - Free!
- MOC Only - Free!
- Community Member - $25
- Professional Member - Free!
- More Information
